Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
36.95 EUR | -3.52% | -4.65% | +4.97% |
May. 21 | Mersen: final ELT mirror delivered to Safran Reosc | CF |
Apr. 26 | Mersen: Amiral Gestion below 5% of share capital | CF |
Sales 2024 * | 1.27B 1.36B | Sales 2025 * | 1.38B 1.49B | Capitalization | 926M 996M |
---|---|---|---|---|---|
Net income 2024 * | 86M 92.44M | Net income 2025 * | 97M 104M | EV / Sales 2024 * | 1.04 x |
Net Debt 2024 * | 393M 423M | Net Debt 2025 * | 432M 464M | EV / Sales 2025 * | 0.98 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
9.52
x | Employees | 7,423 |
Yield 2024 * |
3.28% | Yield 2025 * |
3.57% | Free-Float | 97.69% |
Latest transcript on Mersen
1 day | -2.09% | ||
1 week | -3.23% | ||
Current month | -1.96% | ||
1 month | -2.98% | ||
3 months | +6.23% | ||
6 months | +11.77% | ||
Current year | +6.53% |
Managers | Title | Age | Since |
---|---|---|---|
Luc Themelin
CEO | Chief Executive Officer | 63 | 92-12-31 |
Director of Finance/CFO | 53 | 98-12-31 | |
Sylvie Guiganti
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Legrain
CHM | Chairman | 71 | 17-05-17 |
Emmanuel Blot
BRD | Director/Board Member | 38 | 22-05-18 |
Michel Crochon
BRD | Director/Board Member | 72 | 17-05-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 775 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 36.95 | -3.52% | 17 670 |
24-06-07 | 38.3 | -0.26% | 16,421 |
24-06-06 | 38.4 | +2.13% | 27,591 |
24-06-05 | 37.6 | -1.57% | 35,296 |
24-06-04 | 38.2 | -1.42% | 18,337 |
Real-time Euronext Paris, June 10, 2024 at 03:15 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.53% | 1B | |
+14.68% | 893B | |
+3.63% | 248B | |
-0.44% | 136B | |
+68.63% | 96.68B | |
-8.22% | 71.74B | |
-7.74% | 55.81B | |
+34.39% | 35.41B | |
-40.96% | 30.22B | |
+70.49% | 29.76B |
- Stock Market
- Equities
- MRN Stock